Tangent Medical Technologies, Inc., is a development stage medical device development company formed in 2009 as a spinout from the University of Michigan’s Medical Innovation Center fellowship program.

Tangent was created to address health and safety shortcomings of problems with conventional peripheral intravenous (PIV) fluid/medication delivery systems. Tangent’s patent-pending NovaCath™ represents the next generation of PIV systems for fluid/medication delivery with integrated stabilization and blood containment.

Tangent is a venture capital-backed company located in Ann Arbor, MI.